The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer

Samih Sadek, Mark S. Soloway, Sharon Hook, Francisco Civantos

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose: Patients with transitional cell carcinoma of the bladder are at risk for concurrent or subsequent cancer of the upper tract. Traditionally disease is monitored by radiography (excretory or retrograde urography). Some elect to sample the upper tract by obtaining urine for cytology. Are the results meaningful when performed in a patient with bladder cancer? Materials and Methods: We evaluated 27 consecutive patients with transitional cell cancer of the bladder (grade 1 to 3, Ta to T2) with bladder wash for cytology and cystoscopy as well as resection of visible tumor. A 5F ureteral catheter was positioned at each ureteral orifice, flushed with saline and passed into each renal pelvis. Urine was collected for cytology. Results: Of 19 patients (68%) with high grade (grade 3) bladder cancer 13 had a positive bladder wash, including 6 (32%) with tumor cells detected in the urine from the upper tract. Of 8 patients (38%) with low grade (grade 1 to 2) transitional cell cancer 3 had a positive bladder wash and 2 (25%) had a positive upper tract cytology. All patients had a normal upper tract by excretory or retrograde urography. Ureteroscopy was not performed. Conclusions: Given the normal appearance of the upper urinary tract, it is highly unlikely that most, if any, of these patients with bladder cancer have tumor in the upper tract despite tumor cells in urine obtained by retrograde catheterization. Thus, upper tract sampling by a retrograde technique lacks specificity for localizing transitional cell cancer to the upper tract when performed in a patient with bladder cancer.

Original languageEnglish
Pages (from-to)77-80
Number of pages4
JournalJournal of Urology
Volume161
Issue number1
DOIs
StatePublished - Jan 1 1999

Fingerprint

Urinary Bladder Neoplasms
Cell Biology
Urinary Bladder
Neoplasms
Urine
Urography
Ureteroscopy
Urinary Catheters
Cystoscopy
Kidney Pelvis
Transitional Cell Carcinoma
Urinary Tract
Radiography
Catheterization

Keywords

  • Bladder neoplasms
  • Carcinoma, transitional cell
  • Cytology

ASJC Scopus subject areas

  • Urology

Cite this

The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer. / Sadek, Samih; Soloway, Mark S.; Hook, Sharon; Civantos, Francisco.

In: Journal of Urology, Vol. 161, No. 1, 01.01.1999, p. 77-80.

Research output: Contribution to journalArticle

@article{7638b89665a04abfa0aa4f88763b3624,
title = "The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer",
abstract = "Purpose: Patients with transitional cell carcinoma of the bladder are at risk for concurrent or subsequent cancer of the upper tract. Traditionally disease is monitored by radiography (excretory or retrograde urography). Some elect to sample the upper tract by obtaining urine for cytology. Are the results meaningful when performed in a patient with bladder cancer? Materials and Methods: We evaluated 27 consecutive patients with transitional cell cancer of the bladder (grade 1 to 3, Ta to T2) with bladder wash for cytology and cystoscopy as well as resection of visible tumor. A 5F ureteral catheter was positioned at each ureteral orifice, flushed with saline and passed into each renal pelvis. Urine was collected for cytology. Results: Of 19 patients (68{\%}) with high grade (grade 3) bladder cancer 13 had a positive bladder wash, including 6 (32{\%}) with tumor cells detected in the urine from the upper tract. Of 8 patients (38{\%}) with low grade (grade 1 to 2) transitional cell cancer 3 had a positive bladder wash and 2 (25{\%}) had a positive upper tract cytology. All patients had a normal upper tract by excretory or retrograde urography. Ureteroscopy was not performed. Conclusions: Given the normal appearance of the upper urinary tract, it is highly unlikely that most, if any, of these patients with bladder cancer have tumor in the upper tract despite tumor cells in urine obtained by retrograde catheterization. Thus, upper tract sampling by a retrograde technique lacks specificity for localizing transitional cell cancer to the upper tract when performed in a patient with bladder cancer.",
keywords = "Bladder neoplasms, Carcinoma, transitional cell, Cytology",
author = "Samih Sadek and Soloway, {Mark S.} and Sharon Hook and Francisco Civantos",
year = "1999",
month = "1",
day = "1",
doi = "10.1016/S0022-5347(01)62068-8",
language = "English",
volume = "161",
pages = "77--80",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer

AU - Sadek, Samih

AU - Soloway, Mark S.

AU - Hook, Sharon

AU - Civantos, Francisco

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Purpose: Patients with transitional cell carcinoma of the bladder are at risk for concurrent or subsequent cancer of the upper tract. Traditionally disease is monitored by radiography (excretory or retrograde urography). Some elect to sample the upper tract by obtaining urine for cytology. Are the results meaningful when performed in a patient with bladder cancer? Materials and Methods: We evaluated 27 consecutive patients with transitional cell cancer of the bladder (grade 1 to 3, Ta to T2) with bladder wash for cytology and cystoscopy as well as resection of visible tumor. A 5F ureteral catheter was positioned at each ureteral orifice, flushed with saline and passed into each renal pelvis. Urine was collected for cytology. Results: Of 19 patients (68%) with high grade (grade 3) bladder cancer 13 had a positive bladder wash, including 6 (32%) with tumor cells detected in the urine from the upper tract. Of 8 patients (38%) with low grade (grade 1 to 2) transitional cell cancer 3 had a positive bladder wash and 2 (25%) had a positive upper tract cytology. All patients had a normal upper tract by excretory or retrograde urography. Ureteroscopy was not performed. Conclusions: Given the normal appearance of the upper urinary tract, it is highly unlikely that most, if any, of these patients with bladder cancer have tumor in the upper tract despite tumor cells in urine obtained by retrograde catheterization. Thus, upper tract sampling by a retrograde technique lacks specificity for localizing transitional cell cancer to the upper tract when performed in a patient with bladder cancer.

AB - Purpose: Patients with transitional cell carcinoma of the bladder are at risk for concurrent or subsequent cancer of the upper tract. Traditionally disease is monitored by radiography (excretory or retrograde urography). Some elect to sample the upper tract by obtaining urine for cytology. Are the results meaningful when performed in a patient with bladder cancer? Materials and Methods: We evaluated 27 consecutive patients with transitional cell cancer of the bladder (grade 1 to 3, Ta to T2) with bladder wash for cytology and cystoscopy as well as resection of visible tumor. A 5F ureteral catheter was positioned at each ureteral orifice, flushed with saline and passed into each renal pelvis. Urine was collected for cytology. Results: Of 19 patients (68%) with high grade (grade 3) bladder cancer 13 had a positive bladder wash, including 6 (32%) with tumor cells detected in the urine from the upper tract. Of 8 patients (38%) with low grade (grade 1 to 2) transitional cell cancer 3 had a positive bladder wash and 2 (25%) had a positive upper tract cytology. All patients had a normal upper tract by excretory or retrograde urography. Ureteroscopy was not performed. Conclusions: Given the normal appearance of the upper urinary tract, it is highly unlikely that most, if any, of these patients with bladder cancer have tumor in the upper tract despite tumor cells in urine obtained by retrograde catheterization. Thus, upper tract sampling by a retrograde technique lacks specificity for localizing transitional cell cancer to the upper tract when performed in a patient with bladder cancer.

KW - Bladder neoplasms

KW - Carcinoma, transitional cell

KW - Cytology

UR - http://www.scopus.com/inward/record.url?scp=0032875895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032875895&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(01)62068-8

DO - 10.1016/S0022-5347(01)62068-8

M3 - Article

C2 - 10037373

AN - SCOPUS:0032875895

VL - 161

SP - 77

EP - 80

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 1

ER -